ABSTRACT
INTRODuCTION
Pulmonary embolism (PE) is the most common cause of vascular death after myocardial infarction and stroke, being associated with high mortality and morbidity rates. 1, 2 The incidence of both idiopathic and secondary forms of PE increases exponentially with age, with an average annual incidence of approximately 108 per 100,000 persons. 3, 4 The important consequences of acute PE are related to the alteration of the hemodynamic status of the patients, and is evident when more than 30-40% of the pulmonary arterial bed is occluded by thromboembolism. 5, 6 This occlusion may be life-threating in the acute phase, but the right ventricular failure is potentially reversible. Therefore it is imperative to establish the correct diagnosis at an early stage, when treatment is highly effective. 7 The diagnosis of PE in emergency settings is based mainly on the assessment of the patient's clinical status.
The clinical evaluation ranks patients into several probability categories. In Europe, the most frequently used clinical PE prediction scores are the Wells and Geneva scores. The revised Geneva score is a simple, standardized score based completely on clinical variables. The
Wells score consists of seven clinical criteria. Both scores classify patients into low, moderate or high clinical probability categories. 8, 9 Right ventricular dysfunction, including acute dilation, assessed by cardiac ultrasound is found in at least 25% of patients with PE. Echocardiographic criteria, used for the diagnosis of PE, are usually based on the velocity of the tricuspid regurgitation jet and right ventricular measurements. Echocardiography provides information on the differential diagnosis of cardiogenic shock caused by the PE, by detecting acute valvular dysfunction, cardiac tamponade or myocardial infarction. [10] [11] [12] [13] Electrocardiography (ECG) can show several abnormalities, mostly based on right ventricular (RV) overload, seen as right ventricular dysfunction, but, on their own, none of these different ECG signs are specific enough to confirm the diagnosis of PE. The presence of right bundle branch block and S1Q3T3 patterns in acute PE events appears to be associated with a poorer outcome and RV overload. 14, 15 Currently, plasma D-dimer is not considered a useful biomarker for confirming PE. Normal values of plasma D-dimer can exclude PE in patients with a low or moderate clinical probability. In most countries, computed tomography (CT) angiography, which allows visualization of the pulmonary arteries up to at least the segmental level, has become the method of choice for diagnosing acute PE in patients with high clinical probability or low/moderate probability but elevated D-dimer levels. [16] [17] [18] Various biomarkers have been considered for diagnosing risk categories and prognosis in PE patients. Some studies showed that the N-terminal brain natriuretic peptide (NTproBNP), a biomarker characterizing right ventricular dysfunction, is an indicator of short-term prognosis in PE patients. At the same time, this is a very useful biomarker for monitorization of the in-hospital evolution and the assessment of short-term prognosis associated with the disease. 19, 20 Interestingly, decreased serum levels of total cholesterol and triglycerides have been found to be associated with increased short-term mortality in PE patients, and measurements of cholesterol levels within 24 hours of hospitalization may be valuable in predicting short-term outcomes. 21 The aim of the present study was to assess the factors associated with one-year mortality in patients with acute pulmonary embolism who survived an acute event.
MATERIALS AND METHOD
In total, 104 patients who had survived the acute episode The primary end-point of the study was the all-cause mortality at one year in survivors of acute pulmonary embolism.
Statistical analysis was performed using Graph Pad All patients included in the study gave informed consent, and the study was approved by the Ethics Committee of the Cardio Med Clinic. All the study procedures were performed in agreement with the principles stipulated in the Declaration of Helsinki.
RESuLTS
There Table 1 . There was a significantly higher rate of associated pulmonary pathologies, COPD, asthma, pneumonia, pleural effusion, pulmonary tumors and infiltrative lung disease (p = 0.02). There was also a higher rate of chronic kidney disease (p = 0.04) in the case of patients who died, compared to survivors.
19.04% of patients who had survived had a history of recurrent pulmonary embolism compared to only 10% of the deceased. However, this difference was not statisti-
The etiology of the acute pulmonary embolism episode ( Table 2) Laboratory test results did not show any statistically significant differences between the two groups, except the (Table 4) .
DISCuSSIONS
The results of the study revealed an overall death rate of 19.23% at one year following an acute PE, which is lower in comparison to most other results stated in the literature. A study analyzing 572,773 death records in the USA over a twenty-year period, found that 33.9% of patients had PE as the underlying cause of death. 22 Furthermore, a
European study found that the mortality rates at one year were also higher (37.1%) compared to the results of the present study. 23 The main reason for this difference is explained by the fact that the present study enrolled only patients who had survived the acute event of PE. Thus, those cases who died during hospitalization for acute PE or during the first month were excluded from the analysis. Another study that extracted data from the government database based on age-and gender-specific mor- FIGuRE 3. Left ventricular ejection fraction measured at baseline tality rates concluded that PE remains a significant cause of death, especially in females and the elderly, 24 though a Japanese study showed that PE is an important cause of death in young adults. 25 In the present study, patients who died were significantly older, but there were no differences between the study groups in relation to gender. Stein et al. showed that, despite the fact that obese patients present a higher rate of acute venous thromboembolism, these patients show lower mortality rates compared to normalweight patients. 26 In the present study patients who died had a higher body weight compared to survivors. Nor was the presence of recurrent PE associated with a higher mortality rate at one year. This is in line with the results of the study performed by Dentali et al. which observed that previous venous thromboembolism was significantly associated with 1-year survival rates, a possible explanation being the fact that these patients might be subject to an earlier diagnosis and more rapid treatment. 23 Regarding the hemodynamic parameters, blood pressure values were not different between survivors and the deceased, but a higher peripheral pulse rate was associated with higher mortality. Also, the presence of hemodynamic instability, defined as the presence of shock, inotropic requirement or cardiac arrest during the acute phase of the PE, was associated with a significantly higher death rate for patients who had survived during the onemonth follow-up after an acute PE. Meneveau et al. analyzed the predictors of long-term mortality in patients who had survived the acute phase of PE, and found that the most significant predictors were hemodynamic instability as well as the pulmonary vascular obstruction of more than 70% of the pulmonary bed. 27 Furthermore, hemodynamic instability leading to cardiogenic shock and the need for cardiopulmonary resuscitation are all proved parameters for prediction of in-hospital mortality, however their impact on survivors of the acute phase is relatively unknown. 28 It has been shown that an elevated white blood cell count is associated with a higher risk of thirty-day mortality in PE. 29 In the present study, except from elevated levels of white cell count, no other biomarkers were associated with higher mortality rates in patients with PE, thus
showing that an enhanced inflammatory status during the acute phase is linked with a poorer outcome at one year.
A study investigating the role of ECG in risk stratification for pulmonary embolism demonstrated that the presence of right bundle branch block and the S1Q3T3 pattern were both associated with right ventricular overload and cardiac injury that occurs secondary to PE. 30 Interestingly, the present study showed that patients with a left QRS axis deviation had a higher risk of dying during the oneyear follow-up. However, no difference was found between survivors and the deceased regarding the presence of right bundle branch block, negative T waves in V1-V3 or the presence of the S1Q3T3 pattern on the ECG performed at baseline.
In the present study patients with pulmonary pathologies such as chronic obstructive pulmonary disease, asthma, pneumonia or pleural effusion had a higher mortality rate, and it is concluded that an impaired respiratory function can have a negative impact on the prognosis of PE patients. Also, there was a significant association be- mainly depends on the presence and severity of the associated disease. 31 The presence of malignant conditions has been proved to be a negative predictor of mortality rates in pulmonary embolism. 32 The RIETE registry that included 35,539 venous thromboembolism patients showed that significantly more patients that presented with PE and an associated form of cancer had died by three months, compared to those without any malignant conditions. 33 In the present study, the causes of acute PE, including the presence of neoplasm, deep venous thrombosis or the use of oral contraceptives did not show any influence on the overall mortality rates at one year.
Computed tomography pulmonary angiography (CTPA)
is the current gold standard technique for the diagnosis of PE. 34 Ghanima et al. showed that CTPA could also be used for risk assessment and that several CT parameters are correlated with the right ventricular dysfunction as measured by echocardiography, indicating that CT may be considered a new possible prognostic tool for PE patients. 35 The present study showed no significant differences between survivors and those who died, in regards to thoracic CT angiography. The presence of emboli in both pulmonary arteries was slightly higher in survivors. However, the difference was negligible.
Acute PE has a negative impact on right ventricular (RV) function. RV dysfunction in PE is represented by RV hypokinesis, RV dilation, and signs of pulmonary hypertension. 36 Analysis of the data of the present study showed that the mean RV diameter was similar between the two groups (p = 0.9), and there was no difference between the two groups in relation to the presence of tricuspid regurgitation. However, the left ventricular ejection fraction (LVEF) was significantly lower in patients who died at one year, compared to survivors (p <0.05).
CONCLuSIONS
The clinical factors associated with a higher mortality rate at one year in patients who had survived at one month following an acute pulmonary embolism episode were: older age, higher body weight, the presence of associated pulmonary pathologies, chronic kidney disease and left axis deviation upon ECG examination. Also, left ventricular ejection fraction was significantly lower in patients who had died by one year after a PE episode, and hemodynamic instability requiring inotropic support, cardiogenic shock at presentation or cardiac arrest during the acute phase were significantly associated with one-year mortality rates in acute PE.
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